在肝炎、肝硬化、肝癌“三步曲”的发展进程中,如何精准评估肝脏功能状态,合理科学实施针对性治疗,及时确切判断疗效预后,是对临床医生的挑战,亦是循证医学的要求。而要做到这一点的关键在于严格、规范制定和执行肝脏疾病数字化评估体系。一、肝炎慢性病毒性肝炎依据血清学指标,如丙氨酸氨基转移酶(ALT)和(或)天冬氨酸氨基转移酶(AST)、胆红 In the course of the development of hepatitis, cirrhosis and hepatocellular carcinoma, it is a challenge for clinicians to accurately evaluate the state of liver function, reasonably and scientifically implement targeted treatment, and timely and accurately judge the prognosis of curative effect. It is also evidence-based Medical requirements. The key to do this is to strictly and normatively formulate and implement a digital assessment system for liver disease. First, hepatitis Chronic viral hepatitis based on serological indicators, such as alanine aminotransferase (ALT) and (or) aspartate aminotransferase (AST), bile red